Hizal, M. Et Al. 2022. The Real-Life Efficacy of the Second Line Treatment Strategy in Advanced Pancreas Cancer. Journal of Oncological Science , vol.8, no.2 , 69-75.

Hizal, M., ŞENDUR, M. A. N., Bilgin, B., Karci Güner, E., AKINCI, M. B., Ergün, Y., ... Esin, E.(2022). The Real-Life Efficacy of the Second Line Treatment Strategy in Advanced Pancreas Cancer. Journal of Oncological Science , vol.8, no.2, 69-75.

Hizal, Mutlu Et Al. "The Real-Life Efficacy of the Second Line Treatment Strategy in Advanced Pancreas Cancer," Journal of Oncological Science , vol.8, no.2, 69-75, 2022

Hizal, Mutlu Et Al. "The Real-Life Efficacy of the Second Line Treatment Strategy in Advanced Pancreas Cancer." Journal of Oncological Science , vol.8, no.2, pp.69-75, 2022

Hizal, M. Et Al. (2022) . "The Real-Life Efficacy of the Second Line Treatment Strategy in Advanced Pancreas Cancer." Journal of Oncological Science , vol.8, no.2, pp.69-75.

@article{article, author={Mutlu Hizal Et Al. }, title={The Real-Life Efficacy of the Second Line Treatment Strategy in Advanced Pancreas Cancer}, journal={Journal of Oncological Science}, year=2022, pages={69-75} }